Skip to content

Effects of combination of allograft and xenograft on bone gain in patients undergoing horizontal ridge augmentation: A randomized controlled trial

Effects of combination of allograft and xenograft on bone gain in patients undergoing horizontal ridge augmentation: A randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260203003
Enrollment
38
Registered
2026-02-03
Start date
2026-01-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with horizontal alveolar bone defect requiring dental implant treatment Alveolar bone loss

Interventions

Preoperative prophylaxis antibiotics with Amoxicillin 2 g per oral will be given to patients (Clindamycin 600 mg per oral, if patients are allergic to Penicillin). Local anesthesia will be administere
LifeNet Health, USA) and xenograft (Geistlich Bio-Oss
Geistlich Pharma AG, Switzerland) will be used. After application of bone grafting materials. The graft area will be covered with crosslink collagen membrane (OSSIX Plus
Datum Dental, Israel). Membrane holding suture will be done. Periosteum releasing will be done for reapproximating wound edge with tension free. The wound will be sutured with resorbable suture materi
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Allograft and xenograft,Autograft and xenograft

Sponsors

Faculty of Dentistry, Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Presenting with an edentulous ridge corresponding to one or two missing teeth, 2. The bony defects are classified as Class IV according to the classification of Cawood and Howell, 3. ASA classification I or II, 4. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Patients in vulnerable groups such as dementia, psychiatric conditions, or mental retardation, 2. Patients who are pregnant or lactating, 3. Patients who are smokers, 4. Patients who are taking anticoagulant or antiplatelet agents, 5. Presentation of any pathologic lesions at jaw bone such as cyst or tumor, 6. History of radiation therapy at head and neck region, 7. History of chemotherapy, 8. History of taking antiresorptive agents (such as bisphosphonate, receptor activator of nuclear factor Kappa-B ligand inhibitors) or antiangiogenic agents, 9. History of taking immunosuppressive agents.

Design outcomes

Primary

MeasureTime frame
Bone width gain at preoperative, immediate postoperative, and 9 months postoperative CT scan

Secondary

MeasureTime frame
Bone volume conversion rate at preoperative, immediate postoperative, and 9 months postoperative CT scan,Bone resorption at preoperative, immediate postoperative, and 9 months postoperative CT scan,Complications at postoperative Clinical follow-up,Oral health-related quality of life at preoperative, immediate postoperative, and 9 months postoperative Oral Health Impact Profile-14 questionnaire

Countries

Thailand

Contacts

Public ContactChinnachote Khemla

Faculty of Dentistry, Srinakharinwirot University

chinnachote@g.swu.ac.th026495000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026